Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Chambersburg › NPI 1669523320
Hospital

The Chambersburg Hospital

The Chambersburg Hospital was paid $4.36M by Medicaid between Nov 2019 and Dec 2024, across 238 billing codes. Its largest line is G0378, Hospital observation service, per hour — 26% of everything it billed.

33Billing provider infoTHE CHAMBERSBURG HOSPITAL
CHAMBERSBURG, PA 17201
33aNPI1669523320assigned 01/16/2007
28Total paid$4.36M
24GClaims143,843
24DCodes billed238
24AFirst – last monthNov 2019 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#68 of 154
Median peer was paid$2.82M
This provider vs. median1.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019187$701.29
202018,578$611K
2021104,774$3.27M
20227,209$299K
20236,785$80K
2024incomplete6,310$95K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0378 Hospital observation service, per hour 26% 1,143 1,085 $1.14M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 21% 10,798 10,297 $922K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 7.9% 9,045 3,166 $345K
77067 Screening mammography, bilateral, including computer-aided detection 1.8% 887 869 $79K
80050 General health panel 1.8% 1,693 1,641 $78K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.7% 1,736 546 $75K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1.4% 281 276 $62K
80053 Comprehensive metabolic panel 1.4% 5,980 5,410 $60K
80061 Lipid panel 1.4% 4,344 4,267 $60K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.2% 1,379 1,345 $54K
84443 Thyroid stimulating hormone (TSH) 1.1% 2,233 2,179 $49K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.1% 379 374 $46K
226 more codes
95800 1.1% 471 $46K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 518 $40K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,225 $40K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 129 $36K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 171 $32K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,250 $32K
36415 Collection of venous blood by venipuncture <1% 10,821 $31K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 5,872 $29K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 696 $29K
78815 Positron emission tomography (PET) for limited area imaging <1% 25 $29K
76830 Ultrasound, transvaginal <1% 575 $29K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,100 $26K
97161 <1% 427 $25K
81513 <1% 254 $24K
83036 Hemoglobin; glycosylated (A1C) <1% 3,658 $24K
88142 <1% 1,375 $24K
80081 <1% 255 $23K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 548 $22K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 440 $20K
77063 Screening digital breast tomosynthesis, bilateral <1% 841 $20K
87653 <1% 477 $20K
97162 <1% 370 $19K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,667 $19K
76641 <1% 318 $18K
29580 <1% 197 $18K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 453 $17K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 96 $17K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,112 $17K
59025 Fetal non-stress test <1% 426 $17K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 375 $17K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 449 $16K
84466 <1% 914 $16K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 446 $16K
80048 Basic metabolic panel (calcium, ionized) <1% 2,308 $14K
86803 <1% 720 $14K
87481 <1% 134 $14K
A9585 Injection, gadobutrol, 0.1 ml <1% 826 $13K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 455 $13K
82607 <1% 988 $13K
84702 <1% 821 $12K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 817 $11K
76536 <1% 213 $11K
82728 <1% 878 $10K
83970 <1% 257 $10K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,539 $10K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 299 $10K
84439 <1% 1,154 $9K
82570 <1% 1,284 $9K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 543 $8K
83540 <1% 949 $8K
99213 Doctor's office visit, returning patient (routine) <1% 269 $8K
87077 <1% 1,025 $8K
72110 <1% 369 $8K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 264 $8K
99284 Emergency room visit (serious) <1% 85 $8K
93971 <1% 108 $8K
85027 <1% 1,671 $7K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 1,290 $7K
87186 <1% 858 $7K
97597 <1% 289 $7K
94729 <1% 244 $7K
71046 Radiologic examination, chest; 2 views <1% 530 $7K
93017 <1% 196 $7K
99285 Emergency room visit (most serious) <1% 871 $7K
83735 <1% 1,777 $7K
77065 Tomosynthesis, mammo <1% 90 $7K
77066 Tomosynthesis, mammo <1% 68 $6K
86618 <1% 244 $6K
82043 <1% 787 $6K
94726 <1% 220 $6K
87522 Neg quan hep c or qual rna <1% 140 $6K
71250 <1% 87 $5K
97164 <1% 140 $5K
93226 <1% 131 $5K
84146 <1% 200 $5K
76770 <1% 122 $5K
88304 <1% 631 $5K
85610 <1% 1,731 $5K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 600 $5K
82746 <1% 396 $5K
73221 <1% 16 $5K
87340 <1% 308 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 75 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 60 $4K
84403 <1% 157 $4K
93296 <1% 407 $4K
81001 <1% 1,743 $4K
71275 Computed tomographic angiography, chest, with contrast material <1% 56 $4K
72050 <1% 149 $4K
84481 <1% 169 $4K
86038 <1% 228 $4K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 15 $4K
84550 <1% 588 $4K
70450 Computed tomography, head or brain; without contrast material <1% 142 $3K
86787 <1% 179 $3K
80076 <1% 434 $3K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 60 $3K
86592 <1% 773 $3K
76801 <1% 77 $3K
88342 <1% 70 $3K
72141 <1% 13 $3K
96376 <1% 865 $3K
83721 <1% 271 $3K
83001 <1% 163 $3K
86850 <1% 419 $3K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 260 $3K
82784 <1% 158 $3K
82248 <1% 586 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 51 $3K
84153 <1% 126 $3K
83615 <1% 394 $3K
82950 <1% 361 $2K
84156 <1% 610 $2K
93225 <1% 131 $2K
87070 <1% 365 $2K
82565 <1% 495 $2K
94060 <1% 240 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 90 $2K
87512 <1% 52 $2K
82947 <1% 1,057 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 951 $2K
83880 <1% 130 $2K
87799 <1% 23 $2K
84134 <1% 119 $2K
87081 <1% 350 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 716 $2K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 24 $2K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 42 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 149 $2K
J2785 Injection, regadenoson, 0.1 mg <1% 70 $2K
86003 <1% 13 $2K
85652 <1% 564 $2K
86140 <1% 636 $2K
84402 <1% 54 $2K
87536 <1% 13 $2K
77062 <1% 65 $1K
93975 <1% 13 $1K
85730 <1% 588 $1K
83690 <1% 514 $1K
73564 <1% 76 $1K
82951 <1% 104 $1K
86901 <1% 405 $1K
84100 <1% 396 $1K
86900 <1% 409 $1K
80069 <1% 192 $1K
86762 <1% 73 $1K
87205 <1% 320 $1K
99283 Emergency room visit (moderate) <1% 34 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 273 $1K
86431 <1% 154 $1K
93970 <1% 16 $1K
85018 <1% 369 $1K
85014 <1% 361 $1K
87150 <1% 29 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 25 $1K
87493 <1% 27 $1K
96361 Intravenous infusion, hydration; each additional hour <1% 508 $985.95
84520 <1% 289 $968.55
86480 <1% 13 $944.59
82550 <1% 198 $865.49
87147 <1% 187 $863.85
87427 <1% 65 $806.42
83655 <1% 72 $799.50
87040 <1% 233 $797.28
84484 <1% 753 $793.38
73502 <1% 43 $790.37
84112 <1% 15 $744.34
97014 <1% 36 $715.32
80055 <1% 53 $694.20
74018 <1% 51 $671.95
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 12 $643.75
72040 <1% 40 $615.76
77061 <1% 25 $589.05
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 13 $519.65
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 30 $513.60
82150 <1% 103 $497.68
87045 <1% 66 $456.90
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 12 $454.21
82247 <1% 59 $433.70
84425 <1% 61 $424.85
73030 <1% 27 $410.20
71045 Radiologic examination, chest; single view <1% 560 $395.49
85379 <1% 57 $366.62
82952 <1% 94 $331.55
J2270 Injection, morphine sulfate, up to 10 mg <1% 322 $328.86
83516 <1% 13 $328.13
87046 <1% 66 $327.39
84478 <1% 71 $320.02
82670 <1% 13 $318.23
86376 <1% 41 $312.19
93000 <1% 37 $283.47
83002 <1% 17 $273.70
J1644 Injection, heparin sodium, per 1000 units <1% 232 $269.17
80051 <1% 85 $259.98
83605 <1% 281 $249.21
84144 <1% 12 $238.00
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,404 $195.42
95819 <1% 14 $193.12
84460 <1% 24 $182.16
83525 <1% 15 $165.55
84450 <1% 20 $151.86
73630 <1% 12 $135.59
J1650 Injection, enoxaparin sodium, 10 mg <1% 935 $133.06
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) <1% 42 $130.58
80178 <1% 12 $106.00
81003 <1% 39 $99.64
84145 <1% 24 $83.28
85049 <1% 24 $69.54
J3010 Injection, fentanyl citrate, 0.1 mg <1% 294 $66.70
84132 <1% 19 $55.80
J1815 Injection, insulin, per 5 units <1% 375 $36.35
A9270 Non-covered item or service <1% 85 $33.39
J2704 Injection, propofol, 10 mg <1% 28 $26.70
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 175 $22.01
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 490 $21.57
96367 <1% 20 $5.82
J7030 Infusion, normal saline solution , 1000 cc 0% 868 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 0% 86 $0.00
82805 0% 31 $0.00
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 0% 43 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 20 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 0% 60 $0.00
J3490 Unclassified drugs 0% 1,465 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 93 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 67 $0.00
J2060 Injection, lorazepam, 2 mg 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMASSIMILLA, JOHN (VP)
Same official

Other billing entities under MASSIMILLA, JOHN

Full network →
ProviderLocationPaid
The Chambersburg HospitalChambersburg, PA$3.63M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.